BORDERNETwork Training on
description
Transcript of BORDERNETwork Training on
![Page 1: BORDERNETwork Training on](https://reader036.fdocuments.net/reader036/viewer/2022062520/5681613f550346895dd0a9f2/html5/thumbnails/1.jpg)
BORDERNETwork Training on
Post-Exposure-Prophylaxis Dr. med. Wolfgang Güthoff / Alexander Leffers, M.A.
www.bordernet.euwww.aidshilfe-potsdam.de
![Page 2: BORDERNETwork Training on](https://reader036.fdocuments.net/reader036/viewer/2022062520/5681613f550346895dd0a9f2/html5/thumbnails/2.jpg)
This presentation arises from the BORDERNETwork project which has received funding from the European Union, in the framework of the Health Program, and co-funding of the Ministry of Environment, Health and Consumer Protection of the Federal State of Brandenburg. The sole responsibility of any use that may be made of the information lies with the authors (SPI, AIDS-Hilfe Potsdam e.V.)
![Page 3: BORDERNETwork Training on](https://reader036.fdocuments.net/reader036/viewer/2022062520/5681613f550346895dd0a9f2/html5/thumbnails/3.jpg)
Table of Contents
Transmission
Conditions for PEP
Guidelines on PEP
Blood Control
Problems with PEP
![Page 4: BORDERNETwork Training on](https://reader036.fdocuments.net/reader036/viewer/2022062520/5681613f550346895dd0a9f2/html5/thumbnails/4.jpg)
PEP HIV - Exposure
When?
Injury with HIV contaminated instruments
Wetting of open wounds and mucosa with HIV
contaminated fluids
Unprotected sex with an HIV infected person
Use of HIV contaminated needles (needle sharing)
Transfusion of HIV contaminated blood or blood products
Postexpositionelle Prophylaxe der HIV-Infektion. Gemeinsame Empfehlung der Deutschen AIDS-Gesellschaft (DAIG e.V. und der Österreichischen AIDS-Gesellschaft (ÖAG) et al., in: Dtsch Med. Wochenschr 2009; 134: S 16-S 33.
![Page 5: BORDERNETwork Training on](https://reader036.fdocuments.net/reader036/viewer/2022062520/5681613f550346895dd0a9f2/html5/thumbnails/5.jpg)
PEP - Guidelines
The ultimate goal of PEP is:
• to suppress any viral replication that may occur,
• to shift the biological advantage to the host cellular immune system to prevent or abort early infection
http://www.who.int/hiv/pub/guidelines/PEP/en/
http://www.hivguidelines.org/wp-content/uploads/2009/05/pep_card.pdf
http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5011a1.htm
![Page 6: BORDERNETwork Training on](https://reader036.fdocuments.net/reader036/viewer/2022062520/5681613f550346895dd0a9f2/html5/thumbnails/6.jpg)
Occupational PEP Probability of Transmission
Factors influencing transmission:
Kind of transmitting material(Viral concentration is highest in the blood)
Kind of exposure:• Hollow needle• Cut injury• Open wound• Exposure of mucosa
Viral concentration from index person
Postexpositionelle Prophylaxe der HIV-Infektion. Gemeinsame Empfehlung der Deutschen AIDS-Gesellschaft (DAIG e.V. und der Österreichischen AIDS-Gesellschaft (ÖAG) et al., in: Dtsch Med. Wochenschr 2009; 134: S 16-S 33.
![Page 7: BORDERNETwork Training on](https://reader036.fdocuments.net/reader036/viewer/2022062520/5681613f550346895dd0a9f2/html5/thumbnails/7.jpg)
Average risk:
Percutaneous 0.3%
Mucous membrane 0.1%
Non-intact skin <0.1%
Blood transmission 100%
(non occupational course – unprotected sex 0,03 – 7,5%)
Occupational PEP Probability of Transmission
Postexpositionelle Prophylaxe der HIV-Infektion. Gemeinsame Empfehlung der Deutschen AIDS-Gesellschaft (DAIG e.V. und der Österreichischen AIDS-Gesellschaft (ÖAG) et al., in: Dtsch Med. Wochenschr 2009; 134: S 16-S 33.
![Page 8: BORDERNETwork Training on](https://reader036.fdocuments.net/reader036/viewer/2022062520/5681613f550346895dd0a9f2/html5/thumbnails/8.jpg)
Risk for an HIV-Transmission depending on Exposure in Relation to Average Risk
Kind of Exposure Exposition Risk in Relation to Average Risk
Very deep injury 16 : 1
Visible blood at instrument 5 : 1
Index person has high viral load 6 : 1
Exposure of mucosa 1 : 10
Exposure of damaged skin 1 : 10
Postexpositionelle Prophylaxe der HIV-Infektion. Gemeinsame Empfehlung der Deutschen AIDS-Gesellschaft (DAIG e.V. und der Österreichischen AIDS-Gesellschaft (ÖAG) et al., in: Dtsch Med. Wochenschr 2009; 134: S 16-S 33.
![Page 9: BORDERNETwork Training on](https://reader036.fdocuments.net/reader036/viewer/2022062520/5681613f550346895dd0a9f2/html5/thumbnails/9.jpg)
Occupational PEP Probability of Transmission
High Risk• deep parenteral inoculation via hollow needle• parenteral inoculation with high viral titers
Less Risk• injuries via non-hollow needle• mucosal exposure/non-intact skin exposure
Risk not identified• intact skin exposure• exposure to urine, saliva, tears, sweat
![Page 10: BORDERNETwork Training on](https://reader036.fdocuments.net/reader036/viewer/2022062520/5681613f550346895dd0a9f2/html5/thumbnails/10.jpg)
Exposure Risk
Little information on efficacy of PEP in humans
Seroconversion infrequent following occupational exposure to HIV-
infected blood
Use of Zidovudine (ZDV) was associated with an 81% decrease in
the risk for HIV infection
• limitations include a small number of cases, and that cases
and controls came from different cohorts (Cardo et al, NEJM
1997;337:1485-90.)
![Page 11: BORDERNETwork Training on](https://reader036.fdocuments.net/reader036/viewer/2022062520/5681613f550346895dd0a9f2/html5/thumbnails/11.jpg)
PEP - Conditions
contact with relevant risk of transmission between an HIV-negative
Person and an HIV- infected Person (Index person)
Negative HIV-Test in exposed Person is a condition for PEP
HIV- Rapid Test of Index person
• HIV Rapid Test available?
![Page 12: BORDERNETwork Training on](https://reader036.fdocuments.net/reader036/viewer/2022062520/5681613f550346895dd0a9f2/html5/thumbnails/12.jpg)
PEP - Counselling and Decision(two physicians should get knowledge and experience in this field in every hospital)
Estimation of risk
Decision for PEP: • strongly encourage• recommend• offer• do nothing (counselling is important that the exposed person is assured)
Watch problem situations, discussion of such cases with Dr. Ninfa Ken
or Dr. Pedro Arriaga
Counselling for PEP encloses:• no blood donation for 12 month• safer sex until getting final HIV test after six month• drugs do not have an apply for this indication• written confirmation
![Page 13: BORDERNETwork Training on](https://reader036.fdocuments.net/reader036/viewer/2022062520/5681613f550346895dd0a9f2/html5/thumbnails/13.jpg)
Occupational PEPImmediate Measures
Measurements at cut injuries or needle sticks
• disinfection, wash it with soap and water
Mucosa membrane exposure
• Douche of oral cavity with 70% alcohol: mouth wash 5
times for 15 seconds
Attention!: state of drunkenness will occur
• Douche of eyes with running water
Non intact skin
• Wash with soap, water and antiseptic
Postexpositionelle Prophylaxe der HIV-Infektion. Gemeinsame Empfehlung der Deutschen AIDS-Gesellschaft (DAIG e.V. und der Österreichischen AIDS-Gesellschaft (ÖAG) et al., in: Dtsch Med. Wochenschr 2009; 134: S 16-S 33.
![Page 14: BORDERNETwork Training on](https://reader036.fdocuments.net/reader036/viewer/2022062520/5681613f550346895dd0a9f2/html5/thumbnails/14.jpg)
Post exposure Prophylaxis (PEP)
PEP after occupational HIV-Exposition Transdermal injury with contaminated
hollow needle strongly encourage Superficial injury
(f. e. with surgery needle) offer
Contact of damaged skin with blood offer
Contamination of intact skin do not
recommend Contamination of mucosa
membrane with blood recommend Contamination of mucosa
membrane with urine or saliva do not recommend
Postexpositionelle Prophylaxe der HIV-Infektion. Gemeinsame Empfehlung der Deutschen AIDS-Gesellschaft (DAIG e.V. und der Österreichischen AIDS-Gesellschaft (ÖAG) et al., in: Dtsch Med. Wochenschr 2009; 134: S 16-S 33.
![Page 15: BORDERNETwork Training on](https://reader036.fdocuments.net/reader036/viewer/2022062520/5681613f550346895dd0a9f2/html5/thumbnails/15.jpg)
PEP – when to start and time limits
Entry and Fusion 2h
DNA-Integration in nucleus12h
Viral replication after another12h
PEP within 24h (best - start within first 2h)
>72h after Exposition: PEP is not practical
Replication of HIV and Targets of Therapy
HIV
HIV- entryund Fusion
Reverse Transkriptase
Integrase
Protease
HIV
HIV
HIV
CD4 - cell
Replication of HIV and Targets of Therapy
Postexpositionelle Prophylaxe der HIV-Infektion. Gemeinsame Empfehlung der Deutschen AIDS-Gesellschaft (DAIG e.V. und der Österreichischen AIDS-Gesellschaft (ÖAG) et al., in: Dtsch Med. Wochenschr 2009; 134: S 16-S 33.
![Page 16: BORDERNETwork Training on](https://reader036.fdocuments.net/reader036/viewer/2022062520/5681613f550346895dd0a9f2/html5/thumbnails/16.jpg)
Medications for PEP(German – Austrian Guidelines)
Tenofovir 300mg plusEmtricitabin 200mg
as combination product (Truvada 1x1 pill)
combinedwith
Kaletra (Lopinavir + Ritonavir) 2 x 400/100mg or
Sustiva 1 x 600mg
Alternative:
Combivir 2 x 1 pill(Zidovudin + Lamivudin)
Alternative:Invirase (2 x 1000mg plus Ritonavir 2 x 100mg) or
FosamprenavirIndinavir
Postexpositionelle Prophylaxe der HIV-Infektion. Gemeinsame Empfehlung der Deutschen AIDS-Gesellschaft (DAIG e.V. und der Österreichischen AIDS-Gesellschaft (ÖAG) et al., in: Dtsch Med. Wochenschr 2009; 134: S 16-S 33.
![Page 17: BORDERNETwork Training on](https://reader036.fdocuments.net/reader036/viewer/2022062520/5681613f550346895dd0a9f2/html5/thumbnails/17.jpg)
European Guidelines
HIV- rapid test from Index person If Index person’s HIV-RNA > 1000 copies/ml – testing of drug
resistance Start PEP if possible within 4h and not later then 48h Duration: 4 weeks Medication:
• Truvada (TDF/FTC) 1 x 1 pill
Alternative: Combivir (ZDV/3TC)2 x 1 pill +
• Kaletra (LPVr) 2 x 2 pills
Alternative: Invirase 500(SQV) 2 x2 capsules and Norvir (RTV) 2 x 100mg
Postexpositionelle Prophylaxe der HIV-Infektion. Gemeinsame Empfehlung der Deutschen AIDS-Gesellschaft (DAIG e.V. und der Österreichischen AIDS-Gesellschaft (ÖAG) et al., in: Dtsch Med. Wochenschr 2009; 134: S 16-S 33.
![Page 18: BORDERNETwork Training on](https://reader036.fdocuments.net/reader036/viewer/2022062520/5681613f550346895dd0a9f2/html5/thumbnails/18.jpg)
Blood Controls
Serologic control (HIV, possible HBV, HCV):
at the start
after 6 weeks,
after 3 month
after 6 month
Laboratory tests: at the start, after 2 weeks and after 4 weeks:
Blood count, liver enzymes, kidney function, blood sugar, urine
![Page 19: BORDERNETwork Training on](https://reader036.fdocuments.net/reader036/viewer/2022062520/5681613f550346895dd0a9f2/html5/thumbnails/19.jpg)
Problems regarding HIV – PEP
Pregnancy and lactation period
No substance is harmless!
PEP only at high risk
Experience only with Retrovir and Epivir
Sustiva (Efavirenz) is contraindicated!
![Page 20: BORDERNETwork Training on](https://reader036.fdocuments.net/reader036/viewer/2022062520/5681613f550346895dd0a9f2/html5/thumbnails/20.jpg)
Period between exposition and starting PEP not longer than 24 h
Problems regarding HIV – PEP
![Page 21: BORDERNETwork Training on](https://reader036.fdocuments.net/reader036/viewer/2022062520/5681613f550346895dd0a9f2/html5/thumbnails/21.jpg)
Problems regarding HIV – PEP
High risk through massive inoculation ofinfections material
![Page 22: BORDERNETwork Training on](https://reader036.fdocuments.net/reader036/viewer/2022062520/5681613f550346895dd0a9f2/html5/thumbnails/22.jpg)
Problems regarding HIV – PEP
Strong side effects of HAART (mental – Efavirenz)
![Page 23: BORDERNETwork Training on](https://reader036.fdocuments.net/reader036/viewer/2022062520/5681613f550346895dd0a9f2/html5/thumbnails/23.jpg)
Problems regarding HIV – PEP
Index person gets HAART and drug resistance is probable
• Course of CD4 cells
• Opportunistic infections (OI)
![Page 24: BORDERNETwork Training on](https://reader036.fdocuments.net/reader036/viewer/2022062520/5681613f550346895dd0a9f2/html5/thumbnails/24.jpg)
HIV-Infection known?
How fast is an HIV-test possible?
HIV- rapid tests every time for every physician available?
PEP - Index person
![Page 25: BORDERNETwork Training on](https://reader036.fdocuments.net/reader036/viewer/2022062520/5681613f550346895dd0a9f2/html5/thumbnails/25.jpg)
Treatment AlgorithmDid an exposure to a potentially HIV-infected fluid occur?
Did a significant risk of transmission of HIV occur?(Contact of a HIV negative person with an HIV positive person (index person/source patient)
Is the patient presenting within ideally 2 hours, not later than 72 hours of the exposure?
Can the source patient be interviewed?
Initiation of PEP regimen:• PEP within 24h
(best - start within first 2h)• HIV monitoring
YES
YES
YES
NO
NO
NO
• No indication of PEP
• No follow-up needed
• No indication of PEP
• No follow-up needed
• PEP not indicated
• Follow-up• HIV testing
Adopted from: New York State Department of Health/ AIDS Institute: Recommendations for HIV Postexposure Prophylaxis (PEP)URL: http://www.hivguidelines.org/wp-content/uploads/2009/05/pep_card.pdfAdopted from: Postexpositionelle Prophylaxe der HIV-Infektion. Gemeinsame Empfehlung der Deutschen AIDS-Gesellschaft (DAIG e.V.) und der Österreichischen AIDS-Gesellschaft (ÖAG) et al. in: Dtsch Med. Wochenschr 2009; 134: S 16-S 33.
If yes: interview on HIV status or infection risk, resp. test/rapid test on HIV
If no: belongs the source patient to a high risk group (with high prevalence)
If yes: Individual benefit-risk assessment
If no: PEP not indicated
• Serological test of source patient is confirmed HIV negative
• no evidence of acute retroviral syndrome
• Serological test of source patient is confirmed HIV positive
• Evidence of acute retroviral syndrome occurs
• Source patient is unknown, unwilling etc.
Stop PEP Continue PEP for4 weeks
![Page 26: BORDERNETwork Training on](https://reader036.fdocuments.net/reader036/viewer/2022062520/5681613f550346895dd0a9f2/html5/thumbnails/26.jpg)